OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced the initiation of a Phase 2b clinical trial of TPX-100, its lead therapeutic candidate, in patients with mild to severe ...

TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...

Herantis Pharma Plc - Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease HER-096 is a first-in-class agent in development for ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First ...

Adds nine additional countries to the Company's ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the "MIRACL ...

supported by clinical trials and real-world data from Durasert technology. CFO George Elston reported $318.2 million in cash and investments at the end of Q1 2025, affirming that this positions the ...

Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...

Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 ...

Espoo, Finland, 13 May 2025: Herantis Pharma Plc ("Herantis"), a company developing disease-modifying therapies for Parkinson's disease, today announced the first patients have been dosed in the final ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Autonomix Medical, Inc. has announced its plans to commence a follow-on phase of its proof-of-concept clinical trial, known as PoC 2, which is set to begin in Q2 2025. This phase will further ...